Down Syndrome, Vibration Therapy, Virtual Reality
Conditions
Keywords
down syndrome, children, motor function, balance, muscle strength
Brief summary
To differentiate between the efficacy of virtual reality and whole-body vibration on muscle strength, balance and motor function in children with down syndrome.
Detailed description
Is there difference between the efficacy of virtual reality and whole-body vibration on muscle strength, balance and motor function in children with down syndrome?
Interventions
DEVICEvirtual reality
Participants in Group A underwent therapy using the Wii-Fit program, engaging in 30-minute sessions, three times weekly, for three consecutive months. The Nintendo Wii Fit setup comprises a balance board integrated with a force plate and four pressure sensors, which evaluate the center of pressure (COP) and the distribution of load across the board. The intervention included three sequential exercise sets.
DEVICEwhole body vibration
participated in whole-body vibration (WBV) exercises using the KY-3001 fitness machine. Sessions were conducted three times per week over a period of three months, with each session lasting 30 minutes. Each session began with a 5-10-minute warm-up, which included three minutes of walking followed by stretches targeting the hamstrings, quadriceps, and calves
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
6 Years to 10 Years
Healthy volunteers
No
Inclusion criteria
* The age of children ranged from 6 to 10 years old. * Children who are able to stand independently. * Their heights around one meter or more to meet the assessment criteria of the Biodex balance system. * They are able to follow the verbal commands or instructions.
Exclusion criteria
* Children with deafness and auditory perceptual disorders. * Spinal deformities and foot deformities that interfere with balance. * Epilepsy or seizures. * History of surgical interference in lower limbs. * Botulinum toxin injections of the lower limb prior to the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Muscle strength | 3 months | Muscle strength will be assessed by Hand Held Dynamometer |
| balance | 3 months | Balance will be assessed by Biodex Balance System |
| motor function | 3 months | motor function will be assessed by Gross Motor Function Measure |
Countries
Egypt
Contacts
PRINCIPAL_INVESTIGATORMostafa S. Ali, Phd
Cairo University
Outcome results
None listed